\BOOKMARK [0][-]{chapter*.2}{Abstract}{}% 1
\BOOKMARK [0][-]{chapter*.3}{Acknowledgements}{}% 2
\BOOKMARK [0][-]{chapter*.4}{Declarations}{}% 3
\BOOKMARK [0][-]{chapter*.5}{Submitted Abstracts}{}% 4
\BOOKMARK [0][-]{chapter*.6}{Associated Publications}{}% 5
\BOOKMARK [0][-]{chapter*.7}{Contents}{}% 6
\BOOKMARK [0][-]{chapter*.9}{List of Figures}{}% 7
\BOOKMARK [0][-]{chapter*.10}{List of Tables}{}% 8
\BOOKMARK [0][-]{chapter*.11}{Abbreviations}{}% 9
\BOOKMARK [0][-]{chapter.1}{Establishment of laboratory methods and analytical tools to assess genome-wide chromatin accessibility in clinical samples}{}% 10
\BOOKMARK [1][-]{section.1.1}{Introduction}{chapter.1}% 11
\BOOKMARK [1][-]{section.1.2}{Results}{chapter.1}% 12
\BOOKMARK [2][-]{subsection.1.2.1}{Establishment of an ATAC-seq data analysis pipeline based on current knowledge}{section.1.2}% 13
\BOOKMARK [2][-]{subsection.1.2.2}{Assessment of ATAC-seq transposition times and comparison with FAST-ATAC protocol in relevant cell types}{section.1.2}% 14
\BOOKMARK [2][-]{subsection.1.2.3}{Limitations of ATAC-seq and FAST-ATAC to assess chromatin accessibility in KC}{section.1.2}% 15
\BOOKMARK [0][-]{figure.caption.24}{Appendices}{}% 16
\BOOKMARK [0][-]{appendix.A}{Establishment of methods to assess genome-wide chromatin accessibility}{}% 17
